Koichi Kato Selected Research

arsine

4/2014	Arsine toxicity is induced by inhalation but not by percutaneous exposure in hairless mice.
4/2009	Dimethylarsine likely acts as a mouse-pulmonary tumor initiator via the production of dimethylarsine radical and/or its peroxy radical.
4/2009	Dimethylarsine likely acts as a mouse-pulmonary tumor initiator via the production of dimethylarsine radical and/or its peroxy radical.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Koichi Kato Research Topics

Disease

29	Neoplasms (Cancer) 06/2022 - 08/2004
10	Diabetic Neuropathies (Diabetic Neuropathy) 10/2020 - 09/2002
8	Iron Overload 08/2020 - 01/2013
7	Alzheimer Disease (Alzheimer's Disease) 03/2021 - 11/2009
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 02/2009
7	Parkinson Disease (Parkinson's Disease) 11/2013 - 01/2006
6	Carcinogenesis 01/2022 - 08/2004
6	Infections 01/2022 - 07/2006
5	Muscular Dystrophies (Muscular Dystrophy) 06/2022 - 11/2013
5	Hemochromatosis (Bronze Diabetes) 03/2021 - 07/2016
5	Human Influenza (Influenza) 09/2017 - 02/2008
4	Skin Neoplasms (Skin Cancer) 01/2022 - 10/2004
4	Liver Cirrhosis (Hepatic Cirrhosis) 08/2020 - 12/2003
4	Virus Diseases (Viral Diseases) 12/2011 - 06/2008
3	Hepatocellular Carcinoma (Hepatoma) 10/2022 - 05/2009
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 04/2022 - 10/2018
3	Long QT Syndrome 04/2022 - 03/2014
3	Lung Neoplasms (Lung Cancer) 01/2022 - 12/2018
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2021 - 10/2015
3	Diabetes Complications 10/2020 - 05/2007
3	Hemophilia A (Haemophilia) 01/2020 - 02/2008
3	Hepatolenticular Degeneration (Wilson's Disease) 12/2019 - 03/2017
3	Schizophrenia (Dementia Praecox) 01/2019 - 04/2015
3	Atrophy 10/2018 - 01/2017
3	Meningioma (Meningiomas) 09/2017 - 09/2009
2	Polymorphic catecholergic ventricular tachycardia 12/2022 - 01/2022
2	Fabry Disease (Fabry's Disease) 10/2022 - 02/2021
2	Neuroinflammatory Diseases 01/2022 - 06/2018
2	Poisoning 01/2022 - 04/2014
2	Nervous System Diseases (Neurological Disorders) 01/2021 - 01/2017
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021 - 04/2003
2	Dehydration (Water Stress) 01/2021 - 07/2018
2	Polyneuropathies (Polyneuropathy) 10/2020 - 01/2019
2	Cardiomyopathies (Cardiomyopathy) 10/2020 - 01/2020
2	type 2 Hemochromatosis 08/2020 - 01/2020
2	Heart Failure 08/2020 - 10/2018
2	Anemia 08/2020 - 08/2018
2	Ischemia 07/2020 - 09/2002
2	Hyperferritinemia 01/2020 - 10/2018
2	Guillain-Barre Syndrome 12/2019 - 03/2012
2	Insulin Resistance 07/2019 - 01/2003
2	Melanoma (Melanoma, Malignant) 01/2019 - 01/2019
2	Inflammation (Inflammations) 12/2018 - 10/2012
2	Cognitive Dysfunction 12/2018 - 07/2008
2	Cardiac Arrhythmias (Arrythmia) 10/2018 - 01/2014
2	Wounds and Injuries (Trauma) 12/2017 - 02/2007

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2007
10	Polysaccharides (Glycans)IBA 06/2022 - 01/2008
8	IronIBA 08/2020 - 01/2013
7	ArsenicIBA 01/2022 - 08/2004
7	Glucose (Dextrose)FDA LinkGeneric 10/2019 - 03/2003
6	Amyloid (Amyloid Fibrils)IBA 03/2021 - 02/2009
6	AcidsIBA 12/2018 - 04/2011
5	LectinsIBA 01/2022 - 02/2008
5	GangliosidesIBA 01/2018 - 02/2010
4	Dystroglycans (Dystroglycan)IBA 06/2022 - 11/2013
4	AntigensIBA 01/2022 - 02/2005
4	Amyloidogenic ProteinsIBA 03/2021 - 01/2014
4	metal transporting protein 1 (ferroportin)IBA 03/2021 - 03/2017
4	CopperIBA 12/2019 - 01/2017
4	Aldehyde Reductase (Aldose Reductase)IBA 01/2019 - 09/2002
4	Cacodylic Acid (Cacodylate)IBA 04/2015 - 08/2004
3	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 12/2022 - 01/2022
3	Therapeutic UsesIBA 02/2022 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2009
3	EnzymesIBA 01/2021 - 03/2009
3	Peptides (Polypeptides)IBA 10/2020 - 02/2009
3	Blood Coagulation Factors (Coagulation Factor)IBA 05/2020 - 03/2010
3	Glycoproteins (Glycoprotein)IBA 05/2020 - 06/2009
3	Factor V (Coagulation Factor V)IBA 01/2020 - 02/2008
3	Ferritins (Ferritin)IBA 01/2020 - 03/2017
3	Immunoglobulin G (IgG)IBA 12/2019 - 07/2007
3	AntibodiesIBA 12/2019 - 08/2005
3	polyolIBA 01/2019 - 09/2002
3	isobutyric acidIBA 12/2018 - 10/2012
3	Amino Acid Transport Systems (Amino Acid Transporter)IBA 12/2018 - 05/2015
3	Amino Acids FDA Link 12/2018 - 02/2008
3	Protons (Proton)IBA 07/2018 - 09/2009
3	arsineIBA 04/2014 - 04/2009
3	Amyloid beta-PeptidesIBA 08/2010 - 11/2009
2	alpha-Galactosidase (Beano)IBA 10/2022 - 02/2021
2	Phosphates (Orthophosphate)IBA 06/2022 - 02/2008
2	istradefyllineIBA 01/2022 - 01/2021
2	AsparagineIBA 01/2022 - 01/2019
2	arseniteIBA 01/2022 - 09/2020
2	Indicators and Reagents (Reagents)IBA 01/2021 - 04/2014
2	Antiviral Agents (Antivirals)IBA 01/2021 - 10/2015
2	NAD (NADH)IBA 10/2020 - 01/2019
2	Nonsense Codon (Nonsense Mutation)IBA 10/2020 - 02/2008
2	HepcidinsIBA 08/2020 - 08/2018
2	CarcinogensIBA 05/2020 - 08/2005
2	Complement System Proteins (Complement)IBA 12/2019 - 10/2012
2	epalrestatIBA 01/2019 - 03/2003
2	Ceruloplasmin (Ferroxidase)IBA 08/2018 - 01/2017
2	Familial apoceruloplasmin deficiencyIBA 08/2018 - 01/2017
2	GadoliniumIBA 09/2017 - 01/2011

Therapy/Procedure

19	Therapeutics 10/2022 - 06/2006
4	Transplantation 07/2020 - 06/2005
3	Cell Transplantation 02/2012 - 09/2009
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 04/2022 - 01/2022